advertisement
OBJECTIVE: To establish the efficacy and safety of nonpenetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma. DESIGN: Prospective randomized trial. PARTICIPANTS: Thirty-nine patients (78 eyes) with bilateral primary open-angle glaucoma were included in the study. INTERVENTION: Eyes were randomly assigned to receive deep sclerectomy in one eye and trabeculectomy in the other eye. MAIN OUTCOME MEASURES: Mean intraocular pressure (IOP), postoperative medications, visual acuity, success rate, and complications. RESULTS: At 12 months, mean IOP reduction was 12.3 ± 4.2 (sclerectomy) versus 14.1 ± 6.4 mmHg (trabeculectomy) (p = 0.15), and an IOP ≤21 mmHg was achieved in 36 (92.3%) and 37 eyes (94.9%) (p = 0.9), respectively. Complications included three (7.7%) flat/shallow anterior chambers and one (2.6%) hypotony (trabeculectomy), whereas internal iris incarceration was encountered in two eyes (5.1%) (sclerectomy). CONCLUSIONS: Deep sclerectomy may provide comparable IOP reduction with fewer complications in management of primary open-angle glaucoma.
Dr. F. El Sayyad, El-Maghraby Eye Hospital, Jeddah, Saudi Arabia
12.8.1 Without tube implant (Part of: 12 Surgical treatment > 12.8 Filtering surgery)
12.8.3 Non-perforating (Part of: 12 Surgical treatment > 12.8 Filtering surgery)